FDA Will Reverse Rejection of Third Rare-Disease Drug, Regenxbio Says


The company plans to refile its application for its gene therapy for a fatal brain disease after the FDA dropped demands to give a placebo to some study subjects.

No comments:

Post a Comment

The strangest pets in history